Insights from 2024 ESGO Annual Meeting


 

Risk Stratification of Endometrial Cancer & Selinexor Maintenance for Patients With TP53wt Advanced or Recurrent Disease

173 views
April 25, 2024
Comments 0
Login to view comments. Click here to Login